Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: Verification in a moxidectin-sensitive Australian Shepherd

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 1, 2005, Pages 95-99

  Geyer, J ^a   Doring B ^a   Godoy, J R ^a   Moritz, A ^a   Petzinger, Ernst ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DORAMECTIN; GENOMIC DNA; IVERMECTIN; LOPERAMIDE; MOXIDECTIN; MULTIDRUG RESISTANCE PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BLOOD BRAIN BARRIER; BREED; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC TEST; DOG; DRUG EFFECT; DRUG PENETRATION; DRUG SENSITIVITY; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; MALE; MIOSIS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTINEMATODAL AGENTS; BASE SEQUENCE; DOG DISEASES; DOGS; FRAMESHIFT MUTATION; GENES, MDR; IVERMECTIN; MALE; MOLECULAR SEQUENCE DATA; NEMATODE INFECTIONS; PEDIGREE; POLYMERASE CHAIN REACTION;

ATAXIA; CANIS FAMILIARIS;

EID: 14844346526     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00625.x     Document Type: Article

References (35)

1. Bishop, B.F., Bruce, C.I., Evans, N.A., Goudie, A.C., Gration, K.A., Gibson, S.P., Pacey, M.S., Perry, D.A., Walshe, N.D. & Witty, M.J. (2000) Selamectin: a novel broad-spectrum endectocide for dogs and cats. Veterinary Parasitology, 91, 163-176.
2. Bloomquist, J.R. (2003) Chloride channels as tools for developing selective insecticides. Archives of Insect Biochemistry and Physiology, 54, 145-156.
3. Campbell, W.C., Fisher, M.H., Stapley, E.O., Albers-Schonberg, G. & Jacob, T.A. (1983) Ivermectin: a potent new antiparasitic agent. Science, 221, 823-828.
4. Cordon-Cardo, C., O'Brien, J.P., Casals, D., Rittman-Grauer, L., Biedler, J.L., Melamed, M.R. & Bertino, J.R. (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proceedings of the National Academy of Sciences of the United States of America, 86, 695-698.
5. De Silva, N., Guyatt, H. & Bundy, D. (1997) Anthelmintics. A comparative review of their clinical pharmacology. Drugs, 53, 769-788.
6. 14C moxidectin in cultured rat hepatocytes. Journal of Veterinary Pharmacology and Therapeutics, 24, 171-177.
7. Dupuy, J., Larrieu, G., Sutra, J.F., Lespine, A. & Alvinerie, M. (2003) Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology, 112, 337-347.
8. Hugnet, C., Cadore, J.L., Buronfosse, F., Pineau, X., Mathet, T. & Berny, P.J. (1996) Loperamide poisoning in the dog. Veterinary and Human Toxicology, 38, 31-33.
9. Juliano, R.L. & Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica et Biophysica Acta, 455, 152-162.
10. Kusuhara, H., Suzuki, H., Terasaki, T., Kakee, A., Lemaire, M. & Sugiyama, Y. (1997) P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics, 283, 574-580.
11. Kusuhara, H., Suzuki, H. & Sugiyama, Y. (1998) The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs. Journal of Pharmaceutical Sciences, 87, 1025-1040.
12. Lespine, A., Roulet, A., Dupuy, J., Pineau, T. & Alvinerie, M. (2003) Role of the P-glycoprotein in the cellular efflux of macrocyclic lactones: influence of interfering agents. Journal of Veterinary Pharmacology and Therapeutics. 26 (Suppl. 1), 161-162.
13. Lifschitz, A., Virkel, G., Sallovitz, J., Imperiale, F., Pis, A. & Lanusse, C. (2002) Loperamide-induced enhancement of moxidectin availability in cattle. Journal of Veterinary Pharmacology and Therapeutics, 25, 111-120.
14. Mealey, K.L., Bentjen, S.A., Gay, J.M. & Cantor, G.H. (2001) Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics, 11, 727-733.
15. Mealey, K.L., Northrup, N.C. & Bentjen, S.A. (2003) Increased toxicity of P-glycoprotein-substrate chemotherapeutic agents in a dog with the MDR1 deletion mutation associated with ivermectin sensitivity. Journal of the American Veterinary Medical Association, 223, 1453-1455.
16. Molento, M.B., Lifschitz, A., Sallovitz, J., Lanusse, C. & Prichard, R. (2004) Influence of verapamil on the pharmacokinetics of the anti-parasitic drugs ivermectin and moxidectin in sheep. Parasitology Research, 92, 121-127.
17. Nelson, O.L., Carsten, E., Bentjen, S.A. & Mealey, K.L. (2003) Ivermectin toxicity in an Australian Shepherd dog with the MDR1 mutation associated with ivermectin sensitivity in Collies. Journal of Veterinary Internal Medicine, 17, 354-356.
18. Novotny, M.J., Krautmann, M.J., Ehrhart, J.C., Godin, C.S., Evans, E.I., McCall, J.W., Sun, F., Rowan, T.G. & Jernigan, A.D. (2000) Safety of selamectin in dogs. Veterinary Parasitology, 91, 377-391.
19. Paul, A.J., Tranquilli, W.J., Seward, R.L., Todd, K.S. Jr. & DiPietro, J.A. (1987) Clinical observations in collies given ivermectin orally. American Journal of Veterinary Research. 48, 684-685.
20. Paul, A.J., Tranquilli, W.J. & Hutchens, D.E. (2000) Safety of moxidectin in avermectin-sensitive collies. American Journal of Veterinary Research, 61, 482-483.
21. Pulliam, J.D., Seward, R.L., Henry, R.T. & Steinberg, S.A. (1985) Investigating ivermectin toxicity in Collies. Veterinary Medicine, 80, 33-40.
22. Roulet, A., Puel, O., Gesta, S., Lepage, J.F., Drag, M., Soll, M., Alvinerie, M. & Pineau, T. (2003) MDR1-delicient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. European Journal of Pharmacology, 460, 85-91.
23. Sartor, L.L., Bentjen, S.A., Trepanier, L. & Mealey, K.L. (2004) Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity. Journal of Veterinary Internal Medicine, 18, 117-118.
24. Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C. & te Riele, H.P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491-502.
25. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A. & Borst, P. (1995) Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal of Clinical Investigation, 96, 1698-1705.
26. Schinkel, A.H., Wagenaar, E., Mol, C.A. & van Deemter, L. (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Journal of Clinical Investigation, 97, 2517-2524.
27. Shoop, W., Mrozik, H., & Fisher, M. (1995) Structure and activity of avermectins and milbemycins in animal health. Veterinary Parasitology, 59, 139-156.
28. Tanigawara, Y. (2000) Role of P-glycoprotein in drug disposition. Therapeutic Drug Monitoring, 22, 137-140.
29. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. & Willingham, M.C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences of the United States of America, 84, 7735-7738.
30. Tranquilli, W.J., Paul, A.J. & Seward, R.L. (1989) Ivermectin plasma concentrations in collies sensitive to ivermectin-induced toxicosis. American Journal of Veterinary Research, 50, 769-770.
31. Tranquilli, W.J., Paul, A.J. & Todd, K.S. (1991) Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies. American Journal of Veterinary Research, 52, 1170-1172.
32. Vanapalli, S.R., Hung, Y.P., Fleckenstein, L., Dzimianski, M.T. & McCall, J.W. (2002) Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs. Biopharmaceutics and Drug Disposition, 23, 263-272.
33. Vaughn, D.M., Simpson, S.T., Blagburn, B.L., Whitmer, W.L., Heddens-Mysinger, R. & Hendrix, C.M. (1989) Determination of homovanillic acid, 5-hydroxyindoleacetic acid and pressure in the cerebrospinal fluid of collie dogs following administration of ivermectin. Veterinary Research Communications, 13, 47-55.
34. Wagner, R. & Wendlberger, U. (2000) Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites. Veterinary Parasitology, 93, 149-158.
35. Yas-Natan, E., Shamir, M., Kleinbart, S. & Aroch, I. (2003) Doramectin toxicity in a collie. The Veterinary Record, 153, 718-720.